Preop MRI valuable in detecting additional malignancies in dense & not dense breasts

Newly diagnosed breast cancer patients should undergo a preoperative MRI exam even if their breasts are not dense, a new study indicates. The study found no difference between the usefulness of 3T breast MRI in detecting additional malignancies and high risk lesions in dense versus non-dense breasts.

"There are currently no guidelines that define the role of breast density in determining if a preoperative MRI should be performed. However, anecdotally, we know that preoperative MRI exams tend to be ordered more frequently in younger patients and/or patients with dense breast tissue," said Reena Vashi, MD, one of the authors of the study.

The study of 127 patients, conducted at Yale University School of Medicine in New Haven, CT, found that 3T MRI detected additional malignancies in 26% of patients who had breasts that were not considered dense and in 25% of patients with dense breasts, said Dr. Vashi. There was no difference in the patients with dense breasts compared to those without dense breasts in regard "to the size of lesions detected, or the distribution of the lesions," Dr. Vashi said. In both populations, a significant and statistically similar percentage of patients had unsuspected additional cancers in the opposite breast or in a separate quadrant from the known cancer in the same breast, necessitating a change in surgical management.

This study provides incentive for more research, said Dr. Vashi. "If these results are reproducible, we propose that the decision to perform preoperative breast MRI not be influenced by ," she said.

Related Stories

Preoperative breast MRI suggests high cancer yield

date Jan 12, 2011

The use of preoperative Breast MRI detects otherwise occult cancer with a relatively high degree of accuracy when applied to a diverse population of patients newly diagnosed with breast cancer, according to a study in the ...

Recommended for you

Understanding cancer onset

date 38 minutes ago

Researchers in Malaysia have analysed the genomes of people with a rare genetic disorder to better understand their predisposition to cancer across generations.

Therapy-resistant breast cancer mechanism revealed

date 20 hours ago

Mitsuyoshi Nakao, Director of the Institute of Molecular Embryology and Genetics in Kumamoto University and Associate Professor Noriko Saitoh revealed that a cluster of defined, non-coding RNAs are mechanistically involved ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.